Diseases, Conditions, Syndromes

DLQI with 'not relevant' answers may underrate psoriasis severity

(HealthDay)—The Dermatology Life Quality Index (DLQI) may underestimate disease severity in patients with psoriasis who respond "not relevant" to one or more items, according to a research letter published online April ...

Diseases, Conditions, Syndromes

Classification of psoriasis severity depends on definition

(HealthDay)—Depending on the definition used, there are large variations in the proportion of patients identified as having moderate-to-severe psoriasis, according to a study published in the December issue of the British ...

Diseases, Conditions, Syndromes

Vitamin D could provide psoriasis relief

New research suggests increasing vitamin D intake could reduce the symptoms of chronic inflammatory skin condition psoriasis.

Diseases, Conditions, Syndromes

Psoriasis severity linked to increased risk of type 2 diabetes

People with psoriasis are at a higher risk to develop type 2 diabetes than those without psoriasis, and the risk increases dramatically based on the severity of the disease. Researchers from the Perelman School of Medicine ...

Diseases, Conditions, Syndromes

Promising new treatment option for chronic plaque psoriasis

Affecting more than 6 million Americans, chronic plaque psoriasis manifests as patches of red, scaly skin most frequently on the scalp, elbows and knees. Chronic plaque psoriasis most often appears in adolescence or mid-life ...

Diseases, Conditions, Syndromes

Severe psoriasis predominantly affects men

The fact that men are overrepresented in psoriasis registers and consume more psoriasis care have long led researchers to believe that the common skin disease disproportionally affects men. A unique study with 5,438 Swedish ...

Diseases, Conditions, Syndromes

Drug-induced lupus seen with adalimumab treatment

(HealthDay)—In a case report published online Feb. 12 in the Journal of Clinical Pharmacy and Therapeutics, drug-induced lupus erythematosus (DILE) is described in a patient taking adalimumab for psoriasis.

Surgery

Gastric bypass associated with reduced risk of psoriasis

(HealthDay)—Gastric bypass, but not gastric banding, is associated with reduced risk of psoriasis, progression to severe psoriasis, and psoriatic arthritis, according to a study published online Dec. 21 in JAMA Surgery.

page 3 from 5